Novavax seeks FDA emergency use authorization of its vaccine
(CNN)Novavax announced Monday that it has formally submitted a request for the US Food and Drug Administration to authorize its coronavirus vaccine for emergency use in the United States.
The request is based on data that includes the results of two large clinical trials that demonstrated an overall efficacy of about 90% and a "reassuring safety profile," according to the company.